Clinical Trial Update: Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating albumin-bound paclitaxel (Abraxane) with carboplatin and Herceptin in advanced breast cancer has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• CARBOPLATIN (Carboplatin)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Celgene | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-07-17